Release Date: 28/08/17 13:53 Summary: Appendix 4E and Annual Report Price Sensitive: Yes Download Document 1.49MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%